Dose Delays, Dose Reductions, and Relative Total Dose Intensity in Patients With Advanced Cancer Who Exercised During Neoadjuvant Chemotherapy Treatment
Background: When it comes to chemotherapy, maintaining the dose and schedule of treatment are of vital importance, as clinical evidence suggests that dose intensity is associated with optimal treatment outcomes for various tumors. Yet, reduced dose intensity is a common method of mitigating the chem...
Main Authors: | Karen Y. Wonders PhD, FACSM, Kathryn Schmitz PhD, MPH, FACSM, Jay Harness MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-04-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/15347354231168368 |
Similar Items
-
Plan Assessment Metrics for Dose Painting in Stereotactic Radiosurgery
by: Benjamin Z. Tham, MSc, et al.
Published: (2023-11-01) -
Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab
by: Lize Wang, et al.
Published: (2021-06-01) -
Ultrahigh-Dose-Rate Proton Irradiation Elicits Reduced Toxicity in Zebrafish Embryos
by: Gaëlle Saade, et al.
Published: (2023-03-01) -
Letter in reply: Pericarditis and peripheral edema in a healthy man on low-dose oral minoxidil therapy
by: Kathryn Bentivegna, MPH, et al.
Published: (2022-11-01) -
Efficacy of neoadjuvant chemotherapy combined with low-dose Apatinib in the treatment of triple negative breast cancer
by: Jin-Zhe Yang, et al.
Published: (2023-07-01)